A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)

Clinical trial NCT00818259 · TERMINATED

Trial details

NCT number: NCT00818259
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting

Start date: 2009-02-05
Primary completion: 2014-01-20
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.